T1	Participants 407 477	123 women younger than 70 years of age and at clinical Stages I and II
T2	Participants 514 616	112 were treated by the same surgeon and confirmed pathologically as having invasive mammary carcinoma
T3	Participants 1001 1029	patients with lateral tumors
